Go Pro

Genpact (NYSE:G) Stock Price Up 6.4% - What's Next?

Genpact logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Genpact shares jumped 6.4% to about $34.62, although trading volume was 93% below the stock’s average session volume.
  • Analysts remain cautious, with a consensus “Hold” rating from nine analysts and an average price target of $39.33; recent targets ranged from $31 to $40.
  • Genpact reported quarterly EPS of $1.00 on $1.34 billion in revenue and pays a quarterly dividend of $0.1875, equivalent to a 2.2% annual yield.
  • Interested in Genpact? Here are five stocks we like better.

Genpact Limited (NYSE:G - Get Free Report)'s stock price rose 6.4% during trading on Thursday. The company traded as high as $34.75 and last traded at $34.6180. 164,475 shares were traded during mid-day trading, a decline of 93% from the average session volume of 2,449,872 shares. The stock had previously closed at $32.53.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on G shares. Robert W. Baird lowered their price target on Genpact from $45.00 to $38.00 and set a "neutral" rating for the company in a report on Tuesday, July 7th. Wall Street Zen cut shares of Genpact from a "buy" rating to a "hold" rating in a research report on Saturday, September 12th. Weiss Ratings restated a "hold (c-)" rating on shares of Genpact in a report on Monday, September 21st. BMO Capital Markets reiterated a "market perform" rating and issued a $40.00 target price on shares of Genpact in a report on Friday, August 7th. Finally, Deutsche Bank Aktiengesellschaft set a $31.00 price target on Genpact in a research note on Friday, July 10th. Two analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $39.33.

Get Our Latest Research Report on G

Genpact Trading Up 6.2%

The company has a debt-to-equity ratio of 0.44, a current ratio of 2.00 and a quick ratio of 2.00. The firm has a market cap of $5.81 billion, a PE ratio of 10.24, a price-to-earnings-growth ratio of 0.86 and a beta of 0.58. The company's 50 day moving average price is $35.14 and its 200 day moving average price is $33.75.

Genpact (NYSE:G - Get Free Report) last announced its earnings results on Tuesday, June 30th. The business services provider reported $1.00 earnings per share for the quarter. The firm had revenue of $1.34 billion for the quarter. Genpact had a net margin of 11.04% and a return on equity of 23.34%. As a group, analysts forecast that Genpact Limited will post 3.66 EPS for the current fiscal year.

Genpact Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Investors of record on Thursday, September 10th were issued a $0.1875 dividend. The ex-dividend date was Thursday, September 10th. This represents a $0.75 dividend on an annualized basis and a yield of 2.2%. Genpact's dividend payout ratio (DPR) is 22.26%.

Insiders Place Their Bets

In other Genpact news, SVP Anil Nanduru sold 6,191 shares of the stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $37.03, for a total value of $229,252.73. Following the sale, the senior vice president owned 70,253 shares of the company's stock, valued at $2,601,468.59. This trade represents a 8.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.58% of the stock is currently owned by company insiders.

Institutional Trading of Genpact

A number of large investors have recently made changes to their positions in G. OneAscent Family Office LLC lifted its stake in Genpact by 5.0% in the fourth quarter. OneAscent Family Office LLC now owns 5,991 shares of the business services provider's stock worth $280,000 after acquiring an additional 288 shares during the last quarter. Fifth Third Bancorp increased its position in shares of Genpact by 8.8% in the 1st quarter. Fifth Third Bancorp now owns 3,691 shares of the business services provider's stock valued at $137,000 after purchasing an additional 300 shares during the last quarter. Triad Wealth Partners LLC raised its holdings in shares of Genpact by 3.6% in the 1st quarter. Triad Wealth Partners LLC now owns 8,655 shares of the business services provider's stock valued at $322,000 after purchasing an additional 301 shares in the last quarter. SJS Investment Consulting Inc. lifted its position in shares of Genpact by 22.6% during the 1st quarter. SJS Investment Consulting Inc. now owns 1,692 shares of the business services provider's stock worth $63,000 after purchasing an additional 312 shares during the last quarter. Finally, Basecamp Wealth Advisors LLC grew its stake in shares of Genpact by 54.7% during the first quarter. Basecamp Wealth Advisors LLC now owns 1,046 shares of the business services provider's stock worth $39,000 after purchasing an additional 370 shares in the last quarter. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

About Genpact

(Get Free Report)

Genpact Ltd. NYSE: G is a global professional services and technology company that helps organizations transform business processes and operations. Its services combine consulting, digital technology, data and artificial intelligence, and domain expertise to support process modernization, automation, and operational improvement.

The company provides services across finance and accounting, procurement, supply chain management, customer experience, risk and compliance, lending, and analytics.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines